Europe IoT Infusion Pumps Market Outlook (2022-2033)

The Europe IoT infusion pumps market size is expected to reach US$ 6,718.6 million by 2033 from US$ 1,912.5 million in 2024. The market is estimated to record a CAGR of 15.9% from 2025 to 2033.

Executive Summary and Europe IoT Infusion Pumps Market Analysis:

The IoT infusion pumps market in Europe is experiencing significant growth driven by the increasing demand for precision drug delivery, focus on medication error reduction & patient safety, growth of home infusion therapy. The European IoT infusion pumps market is characterized by maturity, regulatory oversight, and steady adoption across diverse healthcare systems. The region benefits from well-established public healthcare infrastructure, aging populations, and stringent EU MDR regulations that ensure safety and compliance in medical device innovation. Hospitals and clinics dominate usage, deploying IoT-enabled insulin pumps, chemotherapy infusion systems, and syringe pumps to improve treatment precision and reduce adverse events. Germany, France, and the UK lead adoption, supported by advanced hospital networks and strong government-backed digital health initiatives. Competitive dynamics are shaped by multinational corporations such as B. Braun and Fresenius Kabi, who maintain strong regional footprints, while local firms focus on affordability and compliance. Partnerships between device manufacturers and hospital IT providers have created integrated ecosystems that enhance patient outcomes and operational efficiency. Overall, Europe’s market is defined by regulatory-driven innovation, demographic demand, and widespread adoption, positioning it as a stable and mature region for IoT infusion pump deployment.

Europe IoT Infusion Pumps Market Segmentation Analysis

Key segments that contributed to the derivation of the IoT infusion pumps market analysis are product, technology, application, and end user.

• By product, the IoT infusion pumps market is segmented into IoT insulin pumps, syringe infusion pumps, volumetric infusion pumps, ambulatory infusion pumps, patient-controlled analgesia pumps, and others. IoT insulin pumps dominated the market in 2024, driven by the rising diabetes prevalence across aging populations and strong EU regulatory support for connected glucose management.
• By technology, the IoT infusion pumps market is segmented into Wi-Fi, Bluetooth, cellular, and others. Wi-Fi dominated the market in 2024, driven by advanced hospital infrastructure and widespread broadband penetration enabling seamless integration with EU MDR-compliant systems.
• In terms of application, the market is segmented into chemotherapy delivery, diabetes management, pain management, nutritional infusion, and others. Chemotherapy delivery dominated the market in 2024, driven by increasing cancer incidence in Europe and the demand for precise, IoT-enabled oncology infusion therapies.
• By end user, the market is segmented into hospitals & clinics, home care settings, and others. Hospitals & clinics dominated the market in 2024, driven by their central role in public healthcare systems, adopting IoT infusion pumps to enhance efficiency and compliance.

Europe IoT Infusion Pumps Market Outlook

The Europe IoT infusion pumps market is segmented into Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, the Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, the Netherlands, Norway, Portugal, Spain, Sweden, and the United Kingdom. ​‍​‌‍​‍‌​‍​ Looking ahead, Europe’s IoT infusion pumps market is expected to grow steadily, driven by demographic shifts and regulatory frameworks that encourage safe innovation. Rising prevalence of diabetes and cancer continues to fuel demand for connected insulin and chemotherapy pumps, while AI-powered predictive analytics are increasingly integrated into hospital workflows. Connectivity solutions are evolving, with Wi-Fi dominating urban hospitals and secure cloud-based platforms enabling interoperability across healthcare networks. Governments are prioritizing preventive healthcare and digital transformation, embedding IoT infusion pumps into national health strategies. Private healthcare providers are also investing in advanced IoT technologies to differentiate services and attract patients seeking higher standards of care. Challenges remain around affordability, particularly in public healthcare systems, and cybersecurity as devices become more interconnected. Nevertheless, the outlook remains positive, with IoT infusion pumps positioned to reduce hospital admissions, improve patient outcomes, and sustain Europe’s role as a global leader in regulatory-driven digital health innovation.

Europe IoT Infusion Pumps Market Country Insights   

Based on region, the Europe IoT infusion pumps market is further segmented into Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, the Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, the Netherlands, Norway, Portugal, Spain, Sweden, and the United Kingdom. Germany held the largest share in 2024.

Country-level dynamics highlight diverse adoption patterns across Europe. Germany leads with advanced hospital infrastructure and strong compliance with EU MDR standards, making it a hub for IoT infusion pump innovation. France emphasizes affordability and integration within its public healthcare system, while the UK leverages IoT infusion pumps within NHS digital health initiatives. Southern European countries such as Spain and Italy are gradually increasing adoption, driven by aging populations and government-backed e-health programs. Eastern European nations are slower to adopt due to affordability challenges, though donor-funded projects are beginning to introduce IoT monitoring in community health programs. Nordic countries stand out for their high digital health penetration and strong patient acceptance of connected devices. Overall, country insights reveal a heterogeneous but mature landscape, with Europe steadily embedding IoT infusion pumps into national healthcare systems while adapting strategies to local priorities.

Europe IoT Infusion Pumps Market Company Profiles

Medtronic Plc, Moog, Inc., Abbott Laboratories, Boston Scientific Corporation, Baxter International Inc, Becton, Dickinson and Company, B. Braun SE, ICU Medical Inc., Fresenius Kabi AG, Terumo Corporation, are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Europe IoT Infusion Pumps Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Europe IoT Infusion Pumps Key Sources Referred:

• World Health Organization (WHO)
• Organisation for Economic Cooperation and Development (OECD)
• The World Bank Group
• Worldometer
• The Lancet
• International Bar Association
• International Trade Administration
• Eurostat